Following shareholder approval of Mr. Wu Lebin's removal at the Extraordinary General Meeting (EGM), he ceased to be a director immediately upon the EGM's conclusion. Subsequent to Mr. Wu's departure from the Board, BIOSINO BIO-TEC (08247) announced further changes effective July 15, 2025. Mr. Wu concurrently relinquished his positions as member of the Nomination Committee and authorized representative. Mr. Chen Zhengyong, Executive Director and Chairman of the Board, has been appointed as the new authorized representative.

Concurrently, Mr. Lu Qi's resignation as independent non-executive director took effect following the EGM's approval of Mr. Fan Xiaoliang's appointment to that role. With Mr. Lu's departure, the Board confirmed additional adjustments from the same date. Mr. Lu stepped down as Chairman of both the Audit Committee and Nomination Committee, along with his membership on the Remuneration Committee. Mr. Chen Zhengyong has now assumed the role of Chairman of the Nomination Committee.

The EGM also ratified the appointments of Dr. Shen Sheng and Mr. Fan Xiaoliang, who were respectively named Non-Executive Director and Independent Non-Executive Director with effect from July 15, 2025. Following his designation as Independent Non-Executive Director, Mr. Fan Xiaoliang has additionally been appointed Chairman of the Audit Committee from the same effective date.